Short-read Sequencing Market by Technology, Product, Workflow, Application, End-User

KEY MARKET STATISTICS
Base Year [2023]	USD 5.81 billion
Estimated Year [2024]	USD 6.73 billion
Forecast Year [2030]	USD 16.41 billion
CAGR (%)	15.98%

The FPNV Positioning Matrix is pivotal in evaluating the Short-read Sequencing Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Short-read Sequencing Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Short-read Sequencing Market, highlighting leading vendors and their innovative profiles. These include 10x Genomics, Inc., Agilent Technologies, Inc., Almac Group, Azenta Life Sciences, BGI Genomics Co., Ltd., Eurofins Genomics LLC, F. Hoffmann La Roche AG, General Electric Company, Genexa AG, GenScript Biotech Corporation, Illumina, Inc., PerkinElmer, Inc., Qiagen N.V., Seven Bridges Genomics, Inc., and Thermo Fisher Scientific Inc..

Market Segmentation & Coverage

This research report categorizes the Short-read Sequencing Market to forecast the revenues and analyze trends in each of the following sub-markets:

Technology
- Next-Generation Sequencing
- Sanger Sequencing
Product
- Consumables
- Instruments
- Services
Workflow
- Data Analysis
- Pre-Sequencing
- Sequencing
Application
- Agrigenomics & Forensics
- Clinical Investigation
- Consumer Genomics
- HLA Typing & Immune System Monitoring
- Metagenomics, Epidemiology & Drug Development
- Oncology
- Reproductive Health
End-User
- Academic Research
- Clinical Research
- Hospitals & Clinics
- Pharma & Biotech Entities
Region
- Americas
  - Argentina
  - Brazil
  - Canada
  - Mexico
  - United States
    - California
    - Florida
    - Illinois
    - New York
    - Ohio
    - Pennsylvania
    - Texas
- Asia-Pacific
  - Australia
  - China
  - India
  - Indonesia
  - Japan
  - Malaysia
  - Philippines
  - Singapore
  - South Korea
  - Taiwan
  - Thailand
  - Vietnam
- Europe, Middle East & Africa
  - Denmark
  - Egypt
  - Finland
  - France
  - Germany
  - Israel
  - Italy
  - Netherlands
  - Nigeria
  - Norway
  - Poland
  - Qatar
  - Russia
  - Saudi Arabia
  - South Africa
  - Spain
  - Sweden
  - Switzerland
  - Turkey
  - United Arab Emirates
  - United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Short-read Sequencing Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Short-read Sequencing Market?

3. What are the technology trends and regulatory frameworks in the Short-read Sequencing Market?

4. What is the market share of the leading vendors in the Short-read Sequencing Market?

5. Which modes and strategic moves are suitable for entering the Short-read Sequencing Market?

Product Code: MRR-AD36CD8984AC

1. Preface

1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology

2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

4.1. Introduction
4.2. Short-read Sequencing Market, by Region

5. Market Insights

5.1. Market Dynamics
- 5.1.1. Drivers
  - 5.1.1.1. Rising demand for personalized medicine and companion diagnostics
  - 5.1.1.2. Increasing demand attributed to low-cost sequencing in detection of unknown genetic variants in clinical research
  - 5.1.1.3. Surge in demand from application areas such as oncology, infectious disease, reproductive screening and pharmacogenomics
- 5.1.2. Restraints
  - 5.1.2.1. Shortage of skilled professionals and high cost
- 5.1.3. Opportunities
  - 5.1.3.1. Ongoing developments to decrease the cost of genome sequencing
  - 5.1.3.2. Growing collaboration for genetic sequencing
- 5.1.4. Challenges
  - 5.1.4.1. Dearth of required infrastructure in emerging economies
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter's Five Forces Analysis
- 5.5.1. Threat of New Entrants
- 5.5.2. Threat of Substitutes
- 5.5.3. Bargaining Power of Customers
- 5.5.4. Bargaining Power of Suppliers
- 5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework

6. Short-read Sequencing Market, by Technology

6.1. Introduction
6.2. Next-Generation Sequencing
6.3. Sanger Sequencing

7. Short-read Sequencing Market, by Product

7.1. Introduction
7.2. Consumables
7.3. Instruments
7.4. Services

8. Short-read Sequencing Market, by Workflow

8.1. Introduction
8.2. Data Analysis
8.3. Pre-Sequencing
8.4. Sequencing

9. Short-read Sequencing Market, by Application

9.1. Introduction
9.2. Agrigenomics & Forensics
9.3. Clinical Investigation
9.4. Consumer Genomics
9.5. HLA Typing & Immune System Monitoring
9.6. Metagenomics, Epidemiology & Drug Development
9.7. Oncology
9.8. Reproductive Health

10. Short-read Sequencing Market, by End-User

10.1. Introduction
10.2. Academic Research
10.3. Clinical Research
10.4. Hospitals & Clinics
10.5. Pharma & Biotech Entities

11. Americas Short-read Sequencing Market

11.1. Introduction
11.2. Argentina
11.3. Brazil
11.4. Canada
11.5. Mexico
11.6. United States

12. Asia-Pacific Short-read Sequencing Market

12.1. Introduction
12.2. Australia
12.3. China
12.4. India
12.5. Indonesia
12.6. Japan
12.7. Malaysia
12.8. Philippines
12.9. Singapore
12.10. South Korea
12.11. Taiwan
12.12. Thailand
12.13. Vietnam

13. Europe, Middle East & Africa Short-read Sequencing Market

13.1. Introduction
13.2. Denmark
13.3. Egypt
13.4. Finland
13.5. France
13.6. Germany
13.7. Israel
13.8. Italy
13.9. Netherlands
13.10. Nigeria
13.11. Norway
13.12. Poland
13.13. Qatar
13.14. Russia
13.15. Saudi Arabia
13.16. South Africa
13.17. Spain
13.18. Sweden
13.19. Switzerland
13.20. Turkey
13.21. United Arab Emirates
13.22. United Kingdom

14. Competitive Landscape

14.1. FPNV Positioning Matrix
14.2. Market Share Analysis, By Key Player
14.3. Competitive Scenario Analysis, By Key Player

15. Competitive Portfolio

15.1. Key Company Profiles
- 15.1.1. 10x Genomics, Inc.
- 15.1.2. Agilent Technologies, Inc.
- 15.1.3. Almac Group
- 15.1.4. Azenta Life Sciences
- 15.1.5. BGI Genomics Co., Ltd.
- 15.1.6. Eurofins Genomics LLC
- 15.1.7. F. Hoffmann La Roche AG
- 15.1.8. General Electric Company
- 15.1.9. Genexa AG
- 15.1.10. GenScript Biotech Corporation
- 15.1.11. Illumina, Inc.
- 15.1.12. PerkinElmer, Inc.
- 15.1.13. Qiagen N.V.
- 15.1.14. Seven Bridges Genomics, Inc.
- 15.1.15. Thermo Fisher Scientific Inc.
15.2. Key Product Portfolio

16. Appendix

16.1. Discussion Guide
16.2. License & Pricing